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Abstract
Introduction Tracheostomy is one of the more commonly
performed procedures in critically ill patients yet the optimal
method of performing tracheostomies in this population remains
to be established. The aim of this study was to systematically
review and quantitatively synthesize all randomized clinical trials
(RCTs), comparing elective percutaneous dilatational
tracheostomy (PDT) and surgical tracheostomy (ST) in adult
critically ill patients with regards to major short and long term
outcomes.
Methods MEDLINE, EMBASE, CINAHL and the Cochrane
Controlled Clinical Trials Register databases were searched to
identify relevant studies. Additionally, bibliographies and
selected conference proceedings were reviewed, and experts in
the field and manufacturers of two PDT kits were contacted.
Randomized clinical trials comparing any method of elective
PDT to ST that included critically ill adults and reported at least
one clinically relevant outcome were included. Data extracted
included trial characteristics, measures of study validity, and
clinically relevant outcomes.
Results Seventeen RCTs involving 1,212 patients were
included. Most PDTs used a multiple dilator technique and were
performed in the intensive care unit (ICU). The pooled odds ratio
(OR) for wound infection was 0.28 (95% confidence interval
(CI), 0.16 to 0.49, p < 0.0005), indicating a significant reduction
with PDT compared to ST. Overall, PDT was equivalent to ST for
bleeding, major peri-procedural and long-term complications;
however, subgroup analysis suggested PDT resulted in a lower
incidence of bleeding (OR = 0.29 (95% CI 0.12 to 0.75, p =
0.01)) and death (OR = 0.71 (95% CI 0.50 to 1.0, p = 0.05))
when the STs were performed in the operating theatre.
Conclusion PDT reduces the overall incidence of wound
infection and may further reduce clinical relevant bleeding and
mortality when compared with ST performed in the operating
theatre. PDT, performed in the ICU, should be considered the
procedure of choice for performing elective tracheostomies in
critically ill adult patients.
Introduction
Tracheostomy, an ancient surgical procedure originally
described in the first century BC [1], is one of the more com-
monly performed procedures in modern intensive care, and is
predicted to become more common as demand for intensive
care services increases [2,3]. While the benefits of early tra-
cheostomy for patients who require extended periods of
mechanical ventilation, compared to prolonged translaryngeal
intubation, have been recently debated [4-6], the optimal
method of performing tracheostomies in critically ill patients
remains unclear.
The traditional method of performing tracheostomies in criti-
cally ill patients requires transport from the intensive care unit
(ICU) to the operating theatre (OT), where a surgical team per-
forms an open or surgical tracheostomy (ST). This involves a
full dissection of the pretracheal tissues and insertion of the
tracheostomy tube into the trachea under direct vision [7]. Per-
cutaneous dilatational tracheostomy (PDT) was first described
in 1957 [8], and became increasingly popular after the release
of a commercially available kit in 1985 [9]. This technique
involves the use of blunt dilatation to open the pretracheal tis-
sue for passage of the tracheostomy tube. Proponents of PDT
CI = confidence interval; ICU = intensive care unit; OR = odds ratio; OT = operating theatre; PDT = percutaneous dilatational tracheostomy; RCT = 
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suggest that the limited dissection results in less tissue dam-
age, lowers the risk of bleeding and wound infection, and is
able to be performed at the bedside in the ICU, which may
overcome the risks associated with transport of critically ill
patients to the OT [10].
The proportion of patients receiving PDT and ST varies greatly
in different practice settings, with ST being performed exclu-
sively in some ICUs, PDT being performed almost exclusively
in others and others using a mixture of both techniques [11-
14]. Three previous meta-analyses have attempted to resolve
which method of performing tracheostomies is superior; how-
ever, results from these reviews are limited for several reasons.
One included both randomized and non-randomized studies
[15]. The other two meta-analyses included only four [16] and
five [17] randomized trials, respectively, made no attempt to
find unpublished studies, made no assessment of the possible
impact of publication bias, nor explicitly assessed the validity
of those trials included. Current guidelines would suggest that
meta-analyses lacking these features may arrive at unreliable
conclusions [18]. As such, the question of whether PDT or ST
is superior for critically ill patients remains unanswered.
To address these shortcomings and provide a comprehensive
and contemporary overview, we performed a systematic
review and meta-analysis to investigate whether, for adult crit-
ically ill patients who require an elective tracheostomy, PDT is
superior to ST with regards to the incidence of wound infec-
tion, bleeding, and overall mortality as well as major peri-oper-
ative complications. We also examined whether one technique
was associated with improved rates of longer-term complica-
tions.
Materials and methods
Search strategy
Randomized clinical trials (RCTs) comparing PDT with ST in
critically ill patients were identified using both electronic and
manual search strategies supplemented by scanning the bibli-
ographies of all retrieved articles as well as review articles, and
reviewing selected conference proceedings (American Tho-
racic Society (2001 to 2005), Society of Critical Care Medi-
cine (2001 to 2005), European Society of Intensive Care
Medicine (2001 to 2005) and American College of Chest Phy-
sicians (2002 to 2005)). In addition, we searched for unpub-
lished studies by contacting the manufacturers of two
percutaneous tracheostomy kits (Cook® Group Inc, Blooming-
ton, IN, USA) and Smiths Medical (Portex®), London, UK), and
by contacting experts in the field. All languages were consid-
ered eligible. The electronic literature search was completed
on December 31, 2005.
MEDLINE (inception to 2005), EMBASE (inception to 2005),
CINAHL (inception to 2005) and the Cochrane Controlled
Clinical Trials Register databases (inception to 2005) were
searched via OVID. MEDLINE (inception to 2005) was also
search using the Pubmed interface. Three comprehensive
search themes were combined using the Boolean operator
'AND'. The first theme used highly sensitive RCT filters
[19,20]. The second theme was created using exploded med-
ical subject headings (MeSH) and textword search for 'trache-
ostomy' or 'tracheotomy'. The third theme, critical illness, was
created by using the Boolean search term 'OR' to search for
the following terms appearing as both exploded MeSH and
text words: 'critical care' or 'critical illness' or 'intensive care' or
'critically ill'.
Study selection
An initial screen of all titles and abstracts was conducted to
confirm the report was of a trial comparing methods of per-
forming tracheostomies in critically ill patients. The full text arti-
cles were retrieved and assessed to determine if they fulfilled
the predetermined eligibility criteria for inclusion. Two authors
(MN and SB) independently applied the inclusion criteria to
the potentially eligible articles, with disagreements resolved by
discussion or by resort to a third reviewer (AD). When data
were not reported in sufficient detail to determine a studies' eli-
gibility, validity or outcomes, we attempted to contact the cor-
responding author by email for clarification. The report of one
RCT [21] was translated from Korean into English prior to
assessment. To be eligible for inclusion the article had to
describe a study that fulfilled all of the following criteria: study
design – a RCT; intervention – compared any method of elec-
tive PDT to ST; population – included critically ill adults; and
outcomes – reported at least one of the measures bleeding,
wound infection, mortality, duration of mechanical ventilation
or ICU length of stay.
Validity assessment
The validity of the included studies was assessed using a pri-
ori defined criteria. Each study was assessed for the adequacy
of allocation concealment, blinding of outcome assessment,
whether the analysis was conducted on an intention-to-treat
basis, whether the outcomes were prospectively defined, and
whether there were important differences between the two
groups at baseline. When details of the allocation conceal-
ment were not specified in the article or could not be clarified
by contact with the study authors, it was assessed as absent
[22]. Blinding was deemed to be present when there was a
description for a method of blinded assessment of any of the
primary outcomes for that study. Again, two authors (SB and
AD) independently assessed the validity of the studies with
disagreement resolved by discussion.
Data abstraction
Data were abstracted onto standardized data collection forms
by two authors (SB and AD), independently, with disagree-
ments resolved by discussion. Data were collected regarding
patient characteristics, the method of PDT used, the experi-
ence of the operators (whether the procedure was performed
by a trainee or by an attending/consultant), the location whereAvailable online http://ccforum.com/content/10/2/R55
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tracheostomies were performed (ICU or OT), whether the
PDTs were performed under bronchoscopic guidance, and
the duration of translaryngeal intubation prior to tracheostomy.
STs were adjudicated to have been performed in the OT when
any of the participants were transferred to the OT to have the
procedure performed. Outcome data were collected, includ-
ing the incidence of bleeding, wound infection, mortality and
other major complications of the procedures. When available,
data on the duration of mechanical ventilation and duration of
ICU stay were recorded. We attempted to include only clini-
cally important outcomes in our analysis. Wound infection was
defined variably in the primary RCTs (as shown in Additional
file 1), so for our analysis, when possible, only cases that
prompted the administration of systemic antibiotics were
included as wound infection. Bleeding was defined as bleed-
ing that required an intervention, such as need for blood trans-
fusion or surgical hemostasis, rather than bleeding that
resolved spontaneously or with simple pressure. Other major
complications were defined as those that were potentially life
threatening or required an intervention and included loss of the
airway, tube malplacement or pneumothorax. Mortality was
defined as all-cause mortality for the longest period of follow-
up reported in the study or until hospital discharge. Data were
collected on long-term complications when available, includ-
ing incidence of airway symptoms, delayed closure of fistula,
tracheal stenosis, tracheal malacia, and characteristics of the
scar.
Quantitative data synthesis
Agreement on the inclusion of studies was assessed with the
Kappa statistic. Statistical heterogeneity was assessed using
the χ2 and I2 statistics, with an I2 value of >50% indicating at
least moderate heterogeneity [23]. When no statistical heter-
ogeneity was evident, dichotomous data from selected RCTs
were combined using the Mantel and Haenszel method to pro-
duce an estimate of the pooled odds ratio (OR) with 95% con-
fidence intervals (CIs). Continuous outcomes were pooled
using standardized mean differences (SMDs). The potential
for publication bias was assessed by inspection of funnel plots
for asymmetry and an Egger's test [24]. A priori selected sub-
groups for sensitivity analysis included two study quality fac-
tors (allocation concealment and blinding of outcomes), the
method used to perform the PDT, the location where the tra-
cheostomy was performed, and use of bronchoscopic guid-
ance to guide the PDT. All statistical analyses were conducted
using STATA 8.2 (StataCorp, College Station, TX, USA).
Results
Study selection
Database searches generated a total of 1,482 references.
There were 34 full text articles retrieved for review with 17
[21,25-38] RCTs fulfilling all eligibility criteria for inclusion in
the systematic review. While 16 of the studies were identified
by the electronic search strategy, a single study of a recently
completed RCT was identified by contact with an expert [39].
In addition, one study was published in abstract form only;
Figure 1
Quorum flow diagram summarizing trial flow and reasons for exclusion of studies Quorum flow diagram summarizing trial flow and reasons for exclusion of studies. PDT, percutaneous dilatational tracheostomy; RCT, randomized 
clinical trial.C
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Table 1
Characteristics of randomized clinical trials comparing percutaneous dilatational and surgical tracheostomy in critically ill patients
Study No. of 
Participants
Mean age 
(years)
Male (%) Population Method of PDT Location ST 
performed
Location PDT 
performed
ST performed 
by
PDT performed 
by
Use of 
bronchoscopic 
guidance for PDT
Hazard [30] 46 63.1 54.3 Medical/surgical ICU Multiple dilator ICU or OT ICU Staff Trainee No
Crofts [26] 53 59.3 58.5 Medical/surgical ICU Multiple dilator OT ICU Trainee Trainee No
Friedman [28] 53 54.5 58.5 Medical/surgical ICU Multiple dilator OT ICU Staff Trainee No
Holdgaard [32] 60 60 76.7 Medical/surgical ICU Multiple dilator OT OR Trainee Staff No
Jong Joon [21] 38 61 71 Medical ICU Multiple dilator ICU ICU Trainee Trainee Yes
Gysin [29] 70 55.5 NR Medical/surgical ICU Multiple dilator ICU or OT ICU or OT Staff Staff Yes
Porter [34] 24 44.8 79.2 Surgical ICU Multiple dilator ICU ICU Trainee Trainee Yes
Raine [35] 100 43.1 66 Medical/surgical ICU Forceps ICU ICU Staff Staff No
Heikkinen [31] 57 64.6 70.2 Medical/surgical ICU Forceps ICU ICU Staff Staff No
Freeman [27] 80 63.4 46.3 Medical/surgical ICU Multiple dilator OT ICU NR NR Yes
Massick [40] 100 NR NR Medical/surgical ICU Multiple dilator ICU ICU Trainee Trainee Yes
Melloni [33] 50 56.5 62 Medical/surgical ICU Multiple dilator ICU or OT ICU Staff Staff Yes
Sustic [36] 16 36 81.3 Neurosurgical ICU Forceps OT ICU Staff Staff No
Wu [38] 83 68.8 78.3 Medical/surgical ICU Multiple dilator OT ICU Trainee Staff Yes
Antonelli [25] 139 63.5 59.7 Medical/surgical ICU Translaryngeal OT ICU Staff Staff No
Tabaee [37] 43 60.1 39.5 Medical/surgical ICU Single dilator ICU ICU Trainee Trainee Yes
Silvester [39] 200 60.7 68.5 Medical/surgical ICU Multiple dilator ICU ICU Trainee Trainee Yes
ICU, intensive care unit; NR, not reported; OT, operating theatre; PDT, percutaneous dilatational tracheostomy; ST, surgical tracheostomy.Available online http://ccforum.com/content/10/2/R55
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however, the authors were contacted and provided complete
details of the study, which enabled a thorough review and
abstraction of relevant data[35] Agreement on the inclusion
studies was 97% (kappa 0.93, p < 0.0001). The flow of stud-
ies and reasons for exclusion are displayed in Figure 1.
Study description
A total of 1,212 participants were randomized in the 17 RCTs.
The study characteristics are shown in Table 1. The majority
(71%) of PDTs used a multiple dilator technique and 94%
were performed in the ICU. A summary of the validity assess-
ment for the 17 RCTs is displayed in Table 2. Most studies had
balanced groups at baseline and performed their analysis on
an intention-to-treat basis; however, only two RCTs used
methods to blind the adjudication of outcomes while only
seven RCTs clearly maintained allocation concealment. No
study had a loss to follow-up of > 5% for the short-term out-
comes; however, when longer term outcomes were reported,
losses to follow-up were understandably significant, as dis-
played in Table 3.
Evidence synthesis
Wound infection
Clinically important wound infection was diagnosed in 6.6% (n
= 57/870) of patients based on data from 11 RCTs
[25,26,28-30,32,33,36,38-40] (Figure 2). There was a signif-
icant reduction in the OR for wound infection when the trache-
ostomy was performed using the PDT compared with the ST
technique (OR = 0.28; 95% CI, 0.16 to 0.49, p < 0.0005).
There was no evidence of statistical heterogeneity across
studies (χ2 p = 0.43, I2 = 1.0%) or evidence of bias on inspec-
tion of the funnel plot (Additional file 2) or with Eggers test (p
= 0.18).
Bleeding
The overall incidence of clinically relevant bleeding was 5.7%
(n  = 49/861) based on data available from 10 RCTs
[25,27,28,30-32,37-40] (Figure 3). There was no significant
difference in incidence when comparing PDT to ST (OR =
0.80; 95% CI, 0.45 to 1.41, p = 0.35). There was no evidence
of significant statistical heterogeneity across studies (χ2 p =
0.35, I2 = 9.6%) or evidence of bias on inspection of the funnel
plot (Additional file 3) or with Egger's test (p = 0.14).
Mortality
The overall mortality rate was 37% (n = 339/914) based upon
data available from 12 RCTs [25-30,33-35,38,39]. There was
no statistically significant difference in mortality for PDT com-
pared with ST (OR = 0.79; 95% CI, 0.59 to 1.07, p = 0.13)
(Figure 4). There was no evidence of statistical heterogeneity
Table 2
Summary of validity assessments for RCTs comparing percutaneous dilatational and surgical tracheostomy in critically ill patients
Study Allocation 
concealment
Blinding Intention-to-treat 
analysis
Predefined outcomes Baseline Imbalance
Hazard [30] No No Yes Yes No
Crofts [26] No No Yes Yes No
Friedman [28] No No Yes Yes No
Holdgaard [32] Yes No Yes Yes No
Jong Joon [21] No No Yes No No
Gysin [29] No Yes Yes Yes No
Porter [34] Yes No Yes Yes No
Raine [35] Yes No Yes No Yes
Heikkinen [31] No No Yes No No
Freeman [27] Yes No Yes Yes No
Massick [40] Yes No Yes Yes No
Melloni [33] No No Yes Yes No
Sustic [36] No No Yes Yes No
Wu [38] No No No Yes No
Antonelli [25] Yes No Yes Yes No
Tabaee [37] No No Yes Yes No
Silvester [39] Yes Yes Yes Yes No
ICU, intensive care unit; NR, not reported; OT, operating theatre; PDT, percutaneous dilatational tracheostomy; ST, surgical tracheostomy.Critical Care    Vol 10 No 2    Delaney et al.
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across studies (χ2 p = 0.58, I2 = 0%) nor evidence of bias by
either funnel plot asymmetry (Additional file 4) or Egger's test
(p = 0.56).
Other short-term outcomes
Other major complications occurred in 2.6% (n = 15/574) of
patients based on data available from 8 RCTs
[26,28,30,32,34,37,39,40]. There was no significant differ-
ence in the incidence of these major complications between
those randomized to PDT or ST (OR = 1.3; 95% CI, 0.50 to
3.42, p = 0.59) (Additional file 5). There was no evidence of
statistical heterogeneity across studies (χ2 p = 0.95, I2 = 0%).
The duration of translaryngeal intubation prior to tracheostomy
was reported in 15 RCTs [21,25-31,33-39]. There was no dif-
ference in the duration of translaryngeal intubation prior to tra-
cheostomy for patients receiving PDT as opposed to ST
(Additional file 6). The pooled estimate of the SMD was -0.08
days (95% CI, -0.28 to 0.04, p = 0.19). There was no evi-
dence of significant statistical heterogeneity across studies
(χ2 p = 0.30, I2 = 13.4%). The total duration of mechanical
ventilation and total ICU length of stay were not sufficiently
reported to allow pooling of these results.
Effect of study quality on major outcomes
Only two RCTs attempted to perform blinding for the adjudi-
cation of the presence of wound infection. Therefore, the pres-
ence of methods to maintain allocation concealment was the
only study quality factor used to assess for influence on the
pooled effect estimate. The pooled ORs for wound infection,
bleeding and mortality from RCTs where allocation conceal-
ment was maintained were not significantly different from the
Table 3
Summary of long-term complications comparing percutaneous dilatational and surgical tracheostomy in critically ill patients
Study Proportion available for long-term follow-up (%) Duration of follow-up Reported complications
ST PDT Complication ST (%) PDT (%)
Hazard [30] 8/24 (33) 11/22 (50) 1.5–3 months Delayed closure 3 (38) 0 (0)
Tracheal stenosis 5 (63) 2 (18)
Cosmetic deformity 2 (25) 1 (9)
Gysin [29] 20/35 (57) 10/35 (29) 3 months Delayed closure 2 (10) 1 (10)
Tracheal cartilage lesion 1 (5) 0 (0)
Unesthetic scar 8 (40) 2 (20)
Raine [35] 26/50 (52) 24/50 (48) 4 months Tracheal stenosis 11 (46) 7 (27)
Scar requiring surgical 
revision
5 (21) 2 (8)
Heikkinen [31] 11/56 (20) 11/56 (20) 18 months Delayed closure 1 0
Airway symptomsa 22
Dysphagia 1 0
Wu [38] 12/42 (29) 15/41 (37) 2–4 years Tracheal malacia 1 (8) 0 (0)
Melloni [33] 13/25 (52) 15/25 (60) 6 months Tracheal malacia 0 (0) 1 (7)
Tracheal stenosis 0 (0) 1 (7)
Antonelli [25] 13/72 (18) 18/67 (27) 12 months Delayed closure 7 (54) 7 (39)
Airway symptomsa 6 (46) 5 (28)
Tracheal stenosis 2 (11) 1 (6)
Need for stomaplasty 3 (16) 1 (6)
Silvester [39] 42/100 (42) 29/100 (29) 20 months Airway symptomsa 10 (24) 12 (41)
Stridor 2 (5) 0 (0)
Vocal cord paralysis 1 (2) 0 (0)
Unesthetic scar 2 (5) 0 (0)
aAirway symptoms included hoarseness, feeling of a lump in the throat, cough, dyspnea, or subjective phonetic or respiratory problems. PDT, 
percutaneous dilatational tracheostomy; ST, surgical tracheostomy.Available online http://ccforum.com/content/10/2/R55
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ORs from the RCTs when allocation concealment was not
maintained. The results of these analyses are further detailed
in Table 4.
Subgroup analysis
The studies in which the ST was performed in the OT were
pooled separately from those where ST was performed in the
ICU. There was a significant reduction in the incidence of
bleeding with the PDT technique compared to ST, when the
STs were performed in the OT (OR = 0.29; 95% CI, 0.12 to
0.75, p = 0.01). Interestingly, there was a significant reduction
in mortality with the PDT technique, compared to ST, when ST
was performed in the OT (OR = 0.71; 95% CI, 0.50 to 1.0, p
= 0.05). There was a trend toward a shorter duration of
translaryngeal intubation prior to tracheostomy with PDT com-
pared with ST, when the ST were performed in the OT (SMD
= -0.15; 95% CI, -0.31 to 0.02, p = 0.08). Details of the sub-
group analyses are shown in Table 4. The method of PDT used
and use of the bronchoscope to guide the placement of the
PDT did not significantly affect the pooled effect estimates for
wound infection, bleeding or mortality.
Long-term outcomes
Long-term complications for either tracheostomy technique
were reported in eight RCTs and are presented in Table
3[25,29-31,33,35,38,39]. Delayed closure of the stoma, air-
way symptoms, tracheal stenosis and aesthetics of the scar
were the most frequently reported complications; however,
due to low rates of long-term follow-up, it is difficult to draw
definitive inferences from these studies.
Discussion
This systematic review and meta-analysis has demonstrated
that the technique of PDT has a number of important advan-
tages over performing a ST in critically ill patients who require
an elective tracheostomy. First, PDT was associated with a
reduction in the incidence of clinically important wound infec-
tions compared with traditional ST. Secondly, and importantly,
there was no evidence overall that PDT resulted in an
increased incidence of clinically significant bleeding, major
peri-procedural or long term complications. Finally, results of
subgroup analysis suggested that PDT was superior to ST
when the latter was performed in the OT; specifically, PDT
was associated with a reduction in bleeding and overall mor-
tality and a suggestion of decreased duration of translaryngeal
intubation prior to tracheostomy.
It is not surprising that a reduced incidence of wound infection
was found with the PDT technique. One of the reasons that
minimally invasive surgical techniques have become more per-
vasive in many areas of surgery is the reduction in the rates of
surgical site infections [41]. This may be due to minimization
of the local tissue damage with a dilatational technique, or may
in part be due to a relative preservation of immune functions
when minimally invasive techniques are used when compared
to an open technique [42].
While there was no statistically significant reduction in mortal-
ity with either technique, a possible trend towards lower mor-
tality with use of PDT warrants further discussion. One
plausible explanation for this observation could relate to the
Figure 2
Forest plot showing the effect of percutaneous dilatational tracheostomy (PDT) compared to surgical tracheostomy (ST) on the incidence of wound  infection Forest plot showing the effect of percutaneous dilatational tracheostomy (PDT) compared to surgical tracheostomy (ST) on the incidence of wound 
infection.Critical Care    Vol 10 No 2    Delaney et al.
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reduced incidence of infection in those receiving PDT. One
study reported the death of a patient who had a ST that could
be directly attributable to a local wound infection [28]. The
ability to perform the PDT in the ICU without exposing patients
to the risks of transport could contribute as well [43,44]. This
contention would be supported by the reduction in mortality
with PDT when compared to ST performed in the OT. How-
ever, this finding is inconclusive and before a change in clinical
practice could be recommended, this would need confirma-
tion in a larger, adequately powered multi-center randomized
clinical trial.
While subgroup analyses require cautious interpretation in
general, the subgroup analysis in this systematic review pro-
vides some supportive evidence for the advantages of PDT
over ST, in particular when the STs were performed in the OT.
One considerable advantage of PDT is the relative safety and
convenience of performing the procedure at the bedside in the
ICU, which obviates the need to transport a critically ill patient.
The transport of critically ill patients is often logistically difficult
and exposes the patient to increased likelihood for adverse
events and risk to safety [43-46]. The results of our analysis
would support the assertion that the elective transport of criti-
cally ill patients to the OT for ST may pose undue and
increased risk of complications and death.
Additionally, the suggestion of a reduction in the duration of
translaryngeal intubation prior to the procedure when compar-
ing PDT with ST performed in the OT may have several impor-
tant clinical implications. This shorter waiting period prior to
performing the PDT may be due to the ease of organizing the
PDT at the bedside, specifically forgoing the need for a surgi-
cal consultation and the scheduling of time in often busy OTs.
Only two studies [28,39] have examined the time taken from
the decision to perform a tracheostomy to the procedure being
performed. Both found a significantly shorter time when the
tracheostomies were performed using the PDT method. This
may have additional implications for critically ill patients,
including decreased duration of sedation, earlier weaning from
mechanical ventilation and shorter overall length of stay in ICU
[4,47-49].
While long-term complications appear uncommon, the incom-
plete follow-up and lack of consistent definitions of outcome
measurements in the available RCTs make conclusions diffi-
cult to draw with certainty. Non-randomized studies that have
examined this issue have found that clinically relevant tracheal
stenosis was uncommon in PDT when performed by experi-
enced operators in a long-term study of 326 patients [50]. This
experience is not universal [51,52], and further investigation to
determine how the method and timing of tracheostomy affects
long-term outcomes is warranted.
Several clinical trials have compared the various methods of
performing PDT, without any method being shown to be con-
clusively superior [53-56]. As the majority of studies included
in this review used the multiple dilator technique, it is not sur-
prising the results failed to demonstrate any particular benefit
from one specific technique of PDT. While it has been sug-
gested that the use of a bronchoscope to guide the operators
Figure 3
Forest plot showing the effect of percutaneous dilatational tracheostomy (PDT) compared to surgical tracheostomy (ST) on the incidence of signifi- cant bleeding Forest plot showing the effect of percutaneous dilatational tracheostomy (PDT) compared to surgical tracheostomy (ST) on the incidence of signifi-
cant bleeding.Available online http://ccforum.com/content/10/2/R55
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Table 4
Sensitivity analysis for primary outcomes comparing percutaneous dilatational and surgical tracheostomy in critically ill patients
Outcome Subgroup No. of studies Estimate of OR 95% CI Test for between subgroup 
heterogeneity
Infection Allocation concealment P = 0.65
Yes 4 0.33 0.14–0.77
No 7 0.24 0.11–0.53
Method of PDT P = 0.62
Multiple dilator 9 0.24 0.13–0.47
Forceps 1 0.15 0.01–3.74
Translaryngeal 1 0.55 0.15–2.1
ST performed P = 0.70
ICU 2 0.49 0.12–1.99
OT 9 0.25 0.13–0.47
Use of Bronchoscope for PDT P = 0.28
Yes 5 0.40 0.18–0.89
No 6 0.20 0.09–0.46
Bleeding Allocation concealment P = 0.67
Yes 5 0.85 0.46–1.41
No 5 0.71 0.26–1.94
Method of PDT P = 0.33
Multiple dilator 7 0.96 0.51–1.83
Forceps 1 1.7 0.15–20.17
Translaryngeal 1 0.08 0.004–1.37
Single dilator 1 1.5 0.06–39.24
ST performed P = 0.009
ICU 4 2.01 0.86–4.69
OT 6 0.29 0.12–0.75
Use of bronchoscope for PDT P = 0.08
Yes 5 1.36 0.65–2.84
No 5 0.34 0.12–0.92
Mortality Allocation concealment P = 0.86
Yes 5 0.81 0.54–1.22
No 7 0.77 0.50–1.19
Method of PDT P = 0.94
Multiple dilator 9 0.80 0.57–1.11
Forceps 2 0.63 0.16–2.45
Translaryngeal 1 0.84 0.40–1.79
ST performed P = 0.2
ICU 3 1.09 0.61–1.97
OT 9 0.79 0.50–1.00
Use of bronchoscope for PDT P = 0.52
Yes 6 0.86 0.58–1.28
No 6 0.71 0.45–1.12
ICU, intensive care unit; OT, operating theatre; PDT, percutaneous dilatational tracheostomy; ST, surgical tracheostomy.Critical Care    Vol 10 No 2    Delaney et al.
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performing the PDT makes the procedure safer [57], this was
not supported by results of our analysis.
There are a number of potential limitations of our review that
warrant discussion. Firstly, when considering the above find-
ings, it is important to remember that several groups of
patients were excluded from these RCTs, therefore limiting the
generalizability of the results of this meta-analysis to all adult
critically ill populations. Critically ill patients requiring emer-
gency tracheostomy or with evidence or suspicion of difficult
anatomy, prior airway problems, coagulopathies and previous
tracheostomy were generally excluded. Thus, ST may still be
indicated for selected patients, despite the continuing broader
indications for use of PDT [58]. Secondly, while the role of the
experience of the operators performing the procedures was
presented in Table 1, the effect that the experience of the
operators had on the outcomes could not be formally quanti-
tatively assessed in this analysis. Thirdly, there was considera-
ble heterogeneity in the definitions used across studies for the
primary outcomes, in particular wound infection and bleeding.
We have attempted to compensate for this by only reporting
those episodes of wound infection, bleeding or other compli-
cations with obvious clinical relevance, requiring an interven-
tion or that resulted in an alteration to patient management.
Fourthly, the validity of our conclusions is, in part, dependent
upon the validity of the primary RCTs included. Clearly, the
practice of blinding is difficult to perform in surgical trials and
it may not be possible to completely blind the adjudication of
short-term outcomes. One method to partly address this prob-
lem is by setting a priori definitions for primary outcomes, as
was done in some of the RCTs included in this review. In con-
trast, study design to maintain allocation concealment was
conducted or reported in less than half of the reviewed RCTs.
Interestingly, however, those RCTs that reported allocation
concealment produced results similar to the overall pooled
effect estimates. This may suggest that the conclusions of this
meta-analysis are relatively robust to the influence of selected
study quality factors. Finally, while there was no evidence of
potential bias by inspection of the funnel plots, making signifi-
cant publication bias unlikely, it is possible that studies were
not identified for this review that could have had an impact on
the pooled effect estimates.
Several important questions remain to be addressed regard-
ing the use of tracheostomies in critically ill patients. While
there is divided opinion as to the optimal timing of tracheos-
tomy, there is as yet little definitive evidence to guide clinicians
[4]. Similarly, there is a paucity of definitive evidence demon-
strating that one technique of PDT is clearly superior to any
other. Finally, the feasibility of determining whether any tech-
nique of performing a tracheostomy in critically ill patients is
superior with regards to long term outcomes must be ques-
tionable given the difficulties in obtaining a large enough
cohort and adequate follow up to address this issue.
Conclusion
We have demonstrated that use of PDT is associated with a
reduced incidence of wound infection compared to ST in crit-
ically ill patients. PDT may yield an overall decreased risk of
death when compared with ST. While PDT appears equivalent
to ST for the overall incidence of clinically relevant bleeding,
major peri-procedural and long term complications, subgroup
Figure 4
Forest plot showing the effect of percutaneous dilatational tracheostomy (PDT) compared to surgical tracheostomy (ST) on mortality Forest plot showing the effect of percutaneous dilatational tracheostomy (PDT) compared to surgical tracheostomy (ST) on mortality.Available online http://ccforum.com/content/10/2/R55
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analysis has revealed that PDT was superior to ST when the
ST was performed in the OT. These results indicate that PDT,
performed electively in the ICU, should be the method of
choice for performing tracheostomies in critically ill adult
patients.
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